Skip to content
Home » Publications

Publications

2025

Alexandersson BT, Jones MP, Forsberg A, Hedin CRH, Järbrink-Sehgal E, Walter S, Talley NJ, Agreus L, Andreasson A, Schmidt PT. Uncomplicated Diverticulosis Is Not Associated With Abdominal Pain or Abnormal Bowel Habit-A Population-Based Swedish Cohort Study. Neurogastroenterol Motil. 2025 Jun;37(6):e70000. doi: 10.1111/nmo.70000. Epub 2025 Feb 17. PMID: 39962642; PMCID: PMC12075898.

Amutah-Onukagha N, Black A, Harville EW, Gifuni-Koutsouris J, Shah A, Hernandez B, Datta I, Howard S. Equity analysis of a reproductive health association: a case study. Matern Child Health J. 2025 Feb;29(2):164-172. doi: 10.1007/s10995-024-04034-x.

Anderson E J, Peters S L, Gibson P R, Halmos E P. Comparison of digitally delivered gut-directed hypnotherapy program with an active control for irritable bowel syndrome. Am J Gastroenterol. 2025 Feb 1;120(2):440-448. doi: 10.14309/ajg.0000000000002921.

Anderson E J, Peters S L, Gibson P R, Halmos E P. Comparison of digitally delivered gut-directed hypnotherapy program with an active control for irritable bowel syndrome. Am J Gastroenterol. 2025 Feb 1;120(2):440-448. doi: 10.14309/ajg.0000000000002921.

Angel NZ, Sullivan MJ, Alsheikh-Hussain A, Fang L, MacDonald S, Pribyl A, Wills B, Tyson GW, Hugenholtz P, Parks DH, Griffin P, Wood DLA. “Metagenomics: A New Frontier for Routine Pathology Testing of Gastrointestinal Pathogens.” Gut Pathog, vol. 17, no. 1, 18 Jan. 2025, 4. doi:10.1186/s13099-024-00673-1.

Aroney S T N, Newell R J P, Nissen J N, Camargo A P, Tyson G W, Woodcroft B J. CoverM: read alignment statistics for metagenomics. Bioinformatics. 2025 Mar 29;41(4):btaf147. doi: 10.1093/bioinformatics/btaf147.

Aroney S T N, Newell R J P, Tyson G W, Woodcroft B J. “Bin Chicken: Targeted Metagenomic Coassembly for the Efficient Recovery of Novel Genomes.” Nature Methods, 2025. https://doi.org/10.1038/s41592-025-02901-1.

Balk EM, Couch E, Ja Mai H, Chen Y, Adam GP, Kanaan G, Caputo EL, Trikalinos TA, Williams G, Duncanson K, Talley NJ, Lichtenstein AH. Fiber intake and laxation in people with normal bowel function: systematic review. Rockville (MD): Agency for Healthcare Research and Quality (US); 2025 Jul. Report No.: 25-EHC037. doi: 10.23970/AHRQEPCSRLAXATION.

Beasley E, White V, Ugalde A, Brooker J, Skvarc D, Mikocka-Walus A. Effect of third-wave cognitive behavioural interventions on biopsychosocial outcomes in people diagnosed with advanced cancer: a systematic review and meta-analysis of randomised controlled trials. J Psychosom Res. 2025 May;192:112106. doi: 10.1016/j.jpsychores.2025.112106.

Becker S P, Vaughn A J, Zoromski A K, Burns G L, Mikami A Y, Fredrick J W, Epstein J N, Peugh J L, Tamm L. “A Multi-Method Examination of Peer Functioning in Children with and without Cognitive Disengagement Syndrome.” Journal of Clinical Child and Adolescent Psychology, vol. 54, no. 3, May–June 2025, pp. 389–404. https://doi.org/10.1080/15374416.2024.2301771.

Borichevsky GM, Swaminathan A, Smith BR, Edwards TS, Ashby LV, Frampton CMA, Day AS, Gearry RB, Kettle AJ. “Myeloperoxidase Enzyme Activity in Feces Reflects Endoscopic Severity in Inflammatory Bowel Disease.” Inflamm Bowel Dis, vol. 31, no. 8, 1 Aug. 2025, pp. 2254-2268. doi:10.1093/ibd/izaf109.

Bowring J, Parigi E, Karantzas G, Chesterman S, Naude C, Cheah S, Evans S, Skvarc D, Snelling D, Baker E, Mikocka-Walus A. “Biopsychosocial Impacts of Mother Loss on Daughters in Australia: Cross-Sectional Study.” Death Studies, 2025, pp. 1–9. https://doi.org/10.1080/07481187.2025.2491571.

Broeders B, Colomier E, Carbone F, Simrén M, Bai T, Liu J, Melchior C, Gourcerol G, Chuah K H, Hui K X, Mahadeva S, Siah K T H, Gwee K A, Lipták P, Banovcin P, Holtmann G, Koloski N, Carabotti M, Annibale B, Suzuki H, Sano M, Ueda T, Shahoon H, Adibi P, Van de Bruaene C, Vanuytsel T, Tack J. Comparison of the prevalence of meal-related nausea in different functional dyspepsia subgroups. Neurogastroenterol Motil. 2025 Jun 2:e70078. doi: 10.1111/nmo.70078.

Broeders B, Tack J, Talley NJ. Itopride in functional dyspepsia: open-label, 1-year treatment follow-up of two multicenter, randomized, double-blind, placebo-controlled trials. Therap Adv Gastroenterol. 2025 Feb 20;18:17562848251321123. doi: 10.1177/17562848251321123. PMID: 39989849; PMCID: PMC11843690.

Bruce JK, Li LY, Tang Y, Forster E, Winsor NJ, Bi PY, Krustev C, Keely S, Lee JE, Rohde JR, Gaisano HY, Philpott DJ, Girardin SE. Gasdermin-D pores induce an inactivating caspase-4 cleavage that limits IL-18 production in the intestinal epithelium. Commun Biol. 2025 May 13;8(1):737. doi: 10.1038/s42003-025-08183-9.

Bruce J K, Li L Y, Tang Y, Forster E, Winsor N J, Bi P Y, Krustev C, Keely S, Lee J E, Rohde J R, Gaisano H Y, Philpott D J, Girardin S E. “Author Correction: Gasdermin-D Pores Induce an Inactivating Caspase-4 Cleavage That Limits IL-18 Production in the Intestinal Epithelium.” Communications Biology, vol. 8, no. 1, 2025, article 842. https://doi.org/10.1038/s42003-025-08266-7.

Burns G L, Becker S P, Montaño J J, Sáez B, Servera M. Cognitive disengagement syndrome is clinically distinct from ADHD presentations within childhood and adolescence. J Atten Disord. 2025 Sep;29(11):963-976. doi: 10.1177/10870547251344719.

Burns G L, Montaño J J, Becker S P, Servera M. Cognitive disengagement syndrome symptoms from early childhood to adolescence in a nationally representative Spanish sample. J Clin Child Adolesc Psychol. 2025 May-Jun;54(3):374-388. doi: 10.1080/15374416.2023.2272944.

Buttrum P, Young A, Eley D, Banks M, Marsh N, Cruickshank M, Elliott J, Talley N J, Comans T, Bell S C, O’Leary S. Clinicians with formal research qualifications undertaking dual clinical and research activities should be titled and recognised as ‘clinician scientists’. Int J Health Plann Manage. 2025 Dec 3. doi: 10.1002/hpm.70046.

Cameron RA, Jones MP, King SJ, Duncanson KR, Talley NJ. Identification of submucosal eosinophilia in colonic diverticular disease. J Gastroenterol Hepatol. 2025 Dec;40(12):2898-2912. doi: 10.1111/jgh.70122.

Cameron RA, Jones MP, Eslick GD, Talley NJ. Colonic Diverticulosis and Uncomplicated Diverticulitis Are Associated With a Lower Not Higher Risk of Mortality When Confounding Factors Are Held Constant. J Gastroenterol Hepatol. 2025 May;40(5):1221-1229. doi: 10.1111/jgh.16928. Epub 2025 Mar 17. PMID: 40091500; PMCID: PMC12062918.

Camilleri M, Talley NJ. “Mayo Clinic Proceedings in the Last Century: Seminal Contributions by Mayo Clinic Physicians and Researchers to the Field of Neurogastroenterology.” Mayo Clin Proc, vol. 100, no. 9, Sep 2025, pp. 1458-1462. doi:10.1016/j.mayocp.2025.07.012.

Camilleri M, Talley N J. “Are Functional Dyspepsia and Gastroparesis Really ‘Interchangeable’ Diseases?” Gut, 2025. https://doi.org/10.1136/gutjnl-2025-336192.

Cheah S, Skvarc D, Evans S, Van Niekerk L, Mikocka-Walus A. Exploring biopsychosocial health outcomes in endometriosis and endometriosis with co-occurring irritable bowel syndrome – a prospective cohort study. J Psychosom Res. 2025 Dec;199:112404. doi: 10.1016/j.jpsychores.2025.112404.

Chesterman S, Mikocka-Walus A, Sinclair J, Druitt M, Furyk J, Evans S, Abbott J, Eathorne A, Martin A, Ng C, Nguyen L, Oldfield K, Romano D, Sarris J, Semprini A, Stanley K, Armour M. “Challenges in Conducting a Feasibility Randomized Controlled Trial of Medicinal Cannabis for Endometriosis Pain in Australia.” Complementary Therapies in Clinical Practice, vol. 61, 2025, article 102023. https://doi.org/10.1016/j.ctcp.2025.102023.

Chhibba T, Gros B, King JA, Windsor JW, Gorospe J, Leibovitzh H, Xue M, Turpin W, Croitoru K, Ananthakrishnan AN, Gearry RB, Kaplan GG. Environmental risk factors of inflammatory bowel disease: toward a strategy of preventative health. J Crohns Colitis. 2025 Apr 4;19(4):jjaf042. doi: 10.1093/ecco-jcc/jjaf042.

Corsetti M, Zerbib F, Black C, Shin A, Browning K, Keszthelyi D, Jones M. “New Basic Science Editor and New Journal Management Committee Chair of Neurogastroenterology and Motility!” Neurogastroenterol Motil, vol. 37, no. 9, Sep 2025, e70112. doi:10.1111/nmo.70112.

Cosci F, Mikocka-Walus A. Generative artificial intelligence: a hot topic to face with. J Psychosom Res. 2025 May;192:112113. doi: 10.1016/j.jpsychores.2025.112113.

De Araugo SC, Varney JE, McGuinness AJ, Naude C, Evans S, Mikocka-Walus A, Staudacher HM. “Nutrition Interventions in the Treatment of Endometriosis: A Scoping Review.” J Hum Nutr Diet, vol. 38, no. 1, Feb 2025. doi:10.1111/jhn.13411.

Edwards TS, Ho SSC, Brown SC, Appleton L, Smith BR, Borichevsky GM, Swaminathan A, Frampton CMA, Gearry RB, Kettle AJ, Day AS. Fecal myeloperoxidase levels reflect disease activity in children with Crohn’s disease. Inflamm Bowel Dis. 2025 Mar 3;31(3):800-811. doi: 10.1093/ibd/izae262.

Egboh SM, Duncanson K, Potter M, Keely S, Talley NJ. Functional dyspepsia and gastroparesis: are they distinct disorders, a spectrum of diseases or one disease? eGastroenterology. 2025 Jan 23;3(1):e100119. doi: 10.1136/egastro-2024-100119.

El-Omar EM, Gill US, Rees CJ. “Introducing Gut Science-a Fundamental and Discovery Science Companion Journal to Gut.” Gut, vol. 74, no. 12, 10 Nov. 2025, pp. 1943-1944. doi:10.1136/gutjnl-2025-337140.

Engelberts JP, Ye J, Parks DH, McMaster ES, McInnes AS, Woodcroft BJ, Volmer JG, McIlroy SJ, Tyson GW. GenomeFISH: genome-based fluorescence in situ hybridization for strain-level visualization of microbial communities. ISME J. 2025 Jan 2;19(1):wraf138. doi: 10.1093/ismejo/wraf138.

Evans S, Naude C, Coitinho Biurra Y, Bowring J, Knowles S, Brooks T, Skvarc D, Esterman A, Fuller-Tyszkiewicz M, Klas A, Van Niekerk L, McCaffrey N, Stanley K, Druitt M, Andrews J, Vancaillie T, Cheah S, Ciccia D, Blake L, Bassili A, Mikocka-Walus A. “Online Randomised e-Hypnotherapy for Chronic Pelvic Pain Study (REST): Comparing e-Hypnotherapy with Relaxation and Waitlist to Improve Pain, Cost-Effectiveness and Biopsychosocial Outcomes.” BMJ Open, vol. 15, no. 11, 19 Nov. 2025, e102697. doi:10.1136/bmjopen-2025-102697.

Fanous N, Talley NJ, Chaemsupaphan T, Lee E, Rayamajhee B, Baradaran Ghavami S, Kazemifard N, Asadzadeh Aghdaei H, Chuang E, Leong RW. “Microbiota-Targeted Strategies in IBD: Therapeutic Promise of 2′-Fucosyllactose and Beyond.” Therap Adv Gastroenterol, vol. 18, 29 Oct. 2025, 17562848251386319. doi:10.1177/17562848251386319.

Fiedorowicz JG, Mikocka-Walus A. “Journal of Psychosomatic Research 2024 Year in Review.” J Psychosom Res, vol. 192, May 2025, 112125. doi:10.1016/j.jpsychores.2025.112125.

Fisher E, Brown L, Duncanson K. Energy and protein intake threshold modelling using nutrition dashboard technology and sensitivity of hospital malnutrition identification. Nutr Diet. 2025 Sep;82(4):363-372. doi: 10.1111/1747-0080.70007.

Fitzpatrick J A, Gibson P R, Halmos E P. Editorial: inflammatory bowel disease and dietary emulsifiers-a conundrum that continues. Authors’ reply. Aliment Pharmacol Ther. 2025 Jun;61(12):1963-1964. doi: 10.1111/apt.70148.

Fitzpatrick J A, Gibson P R, Taylor K M, Anderson E J, Friedman A B, Ardalan Z S, Smith R L, Halmos E P. “Clinical Trial: The Effects of Emulsifiers in the Food Supply on Disease Activity in Crohn’s Disease: An Exploratory Double-Blinded Randomised Feeding Trial.” Alimentary Pharmacology & Therapeutics, vol. 61, no. 8, Apr 2025, pp. 1276–1289. https://doi.org/10.1111/apt.70041.

Forbes A J, Day A S, Frampton C M A, Gearry R B. Compounding prevalence of inflammatory bowel disease in a 2024 population-based study from Canterbury, New Zealand. JGH Open. 2025 May 30;9(6):e70192. doi: 10.1002/jgh3.70192.

Forbes AJ, Day AS, Frampton CMA, Gearry RB. Incidence of inflammatory bowel disease in Canterbury, New Zealand, 2018-2023. Dig Dis Sci. 2025 Feb;70(2):719-727. doi: 10.1007/s10620-024-08811-0.

Forbes A J, Frampton C M A, Day A S, Gearry R B. “20-Year Mortality in a Population-Based Cohort of Patients with Inflammatory Bowel Disease from New Zealand.” Digestive Diseases and Sciences, vol. 70, no. 10, 2025, pp. 3465–3475. https://doi.org/10.1007/s10620-025-09180-y.

Fowler S, Paech G M, Hoedt E C, Pryor J C, Nieva C, Bruce J K, Nair P M, Eslick G D, Sherwin S, Pockney P, Talley N J, Burns G L, Keely S. “Altered Peripheral CRY1 Gene Expression May Contribute to Both Organic and Functional Gastrointestinal Disease.” Experimental Physiology, 2025. https://doi.org/10.1113/EP092725.

Grant-St James A, Lee A C, Lee A J, Wist J, Sohel F, Wong K W, Yeap B B, Loo R L, Henry A, Susic D, El-Omar E, Nicholson J K, Holmes E, Whiley L, Gray N. “Analytical Quality Control in Targeted Lipidomics: Evaluating the Performance of Commercial Plasma as a Surrogate for Pooled Study Samples.” Analytica Chimica Acta, vol. 1365, 2025, article 344225. https://doi.org/10.1016/j.aca.2025.344225.

Halmos E P, Gibson P R. Editorial: efficacy of pharmacological compared with dietary therapy for patients with irritable bowel syndrome-it is nice to have a choice. Aliment Pharmacol Ther. 2025 Nov 24. doi: 10.1111/apt.70452.

Hanžel J, Solitano V, Vuyyuru S K, Panaccione R, Sands B E, Peyrin-Biroulet L, Danese S, D’Haens G R, Atreya R, Allez M, Bernstein C N, Bossuyt P, Bressler B, Bryant R V, Cohen B L, Colombel J F, D’Amico F, Dignass A, Dubinsky M, Fleshner P, Gearry R B, Hanauer S B, Hart A L, Kayal M, Kucharzik T, Lakatos P L, Louis E, Magro F, Narula N, Leong R W, Panés J, Raine T, Ran Z, Regueiro M D, Reinisch W, Singh S, Steinhart A H, Travis S, Ungaro R C, van der Woude C J, Yamamoto T, Ahuja V, Rubin D T, Dulai P S, Cornfield L J, Hogan M, Sandborn W J, Feagan B G, Jairath V, Ma C. “An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease.” Gastroenterology, vol. 169, no. 6, Nov 2025, pp. 1282–1293. https://doi.org/10.1053/j.gastro.2025.05.015.

Henström M, Esplin T, Schwartzkoff E, Duncanson K, Popovic G, Ball R. Engaging parents with child nutrition and feeding information on Facebook: a retrospective content analysis. Food Sci Nutr. 2025 May 25;13(6):e70326. doi: 10.1002/fsn3.70326.

Hicks C, Leonardi M, Chua XY, Mari-Breedt L, Espada M, El-Omar EM, Condous G, El-Assaad F. “Oral, Vaginal, and Stool Microbial Signatures in Patients with Endometriosis as Potential Diagnostic Non-Invasive Biomarkers: A Prospective Cohort Study.” BJOG, vol. 132, no. 3, Feb 2025, pp. 326-336. doi:10.1111/1471-0528.17979.

Hoedt EC, Carroll GM, Stephensen BD, Morrison M, Vishnoi V, Cuskelly A, Draganic BD, McManus B, Clarke L, Shah KH, Smith SR, Talley NJ, Keely S, Pockney P. Preoperative Antibiotics and Mechanical Bowel Preparation Impact the Colonic Mucosa-Associated Microbiota but Not Anastomotic Leak Rate After Colorectal Resection. Dis Colon Rectum. 2025 Jul 1;68(7):875-886. doi: 10.1097/DCR.0000000000003775. Epub 2025 Apr 11. PMID: 40214103.

Hoedt, EC, Burns GL , Kang S, Bruce J, Morrison M, Keely S, Talley NJ  “Altered Duodenal Mucosa-Associated Microbiota and Immune Profiles in Functional Dyspepsia: A Study of Host-Microbiome Homeostasis.” bioRxiv (Cold Spring Harbor Laboratory), Apr. 2025, https://doi.org/10.1101/2025.04.10.648308.

Holtmann G, Moniruzzaman M, Shah A; Australian Gastrointestinal Research Alliance (AGIRA); NHMRC Centre for Research Excellence in Digestive Health. Decoding the gut-brain axis: a journey toward targeted interventions for disorders-of-gut-brain interaction. Dig Dis. 2025;43(3):257-265. doi: 10.1159/000543845.

Honap S, Jairath V, Sands B E, Dulai P S, Higgins P D R, De Cruz P, Gutiérrez A, Kotze P G, Ye B D, Kobayashi T, Gearry R B, Olivera P A, Amiot A, Mosli M H, Al Awadhi S, Halfvarson J, Patel K V, Sebastian S, Danese S, Peyrin-Biroulet L. “Acute Severe Ulcerative Colitis: An International Delphi Consensus on Clinical Trial Design and Endpoints.” Clinical Gastroenterology and Hepatology, vol. 23, no. 8, July 2025, pp. 1408–1417.e4. https://doi.org/10.1016/j.cgh.2024.10.029.

Humphries S, Burnard SM, Eggins CD, Keely S, Bond DR, Lee HJ. Hypoxia impairs decitabine-induced expression of HLA-DR in acute myeloid leukaemia cell lines. Clin Epigenetics. 2025 Jan 17;17(1):8. doi: 10.1186/s13148-025-01812-4.

Katz C, Evans S, Mikocka-Walus A. ‘Listen to women as if they were your most cherished person’: Australian women’s perspectives on living with the pain of endometriosis: a mixed-methods study. J Health Psychol. 2025;30(8):1899-1914. doi:10.1177/13591053241250101.

Keely S, Duncanson K. Digesting the influence of diet and exercise on the microbiome. J Physiol. 2025 Sep 17. doi: 10.1113/JP289733.

Keely S, Hoedt E C, Pockney P. “Author Reply: Mechanical Bowel Preparation’s Influence on the Microbiome in Anastomotic Leak.” Diseases of the Colon & Rectum, vol. 68, no. 12, Dec 2025, p. e1956. https://doi.org/10.1097/DCR.0000000000003956.

Kellar T, Basnayake C, Burgell RE, Kamm M, Kim HW, Lane K, Murphy K, Talley NJ. Disorders of gut-brain interaction, eating disorders and gastroparesis: a call for coordinated care and guidelines on nutrition support. Med J Aust. 2025 Jan 13;222(1):10-12. doi: 10.5694/mja2.52537. Epub 2024 Nov 24. PMID: 39582157.

Kellermayer R, Lewindon P, Buness C, Tabibian J, Johnson K, Shah S, Dulai P, Ali A H, Shah A, Holtmann G, Winter H S. Comment on “Effectiveness and safety of oral vancomycin for the treatment of inflammatory bowel disease associated with primary sclerosing cholangitis: a systematic review and pooled analysis”. Therap Adv Gastroenterol. 2025 Apr 21;18:17562848251332453. doi: 10.1177/17562848251332453.

Koloski NA, Jones MP, Shah A, Holtmann G, Talley NJ. Evidence for brain-to-gut and gut-to-brain pathways in primary care patients with disorders of gut-brain interaction, inflammatory bowel disease and gastroesophageal reflux disease. Neurogastroenterol Motil. 2025 Dec;37(12):e70117. doi: 10.1111/nmo.70117.

Krebs J D, Parry-Strong A, Braakhuis A, Worthington A, Merry T L, Gearry R B, Foster M, Weatherall M, Davies C, Mullaney J, Ross C, Conroy D, Rolleston A, Lithander F E. “A Mediterranean Dietary Pattern Intervention Does Not Improve Cardiometabolic Risk but Does Improve Quality of Life and Body Composition in an Aotearoa New Zealand Population at Increased Cardiometabolic Risk: A Randomised Controlled Trial.” Diabetes, Obesity and Metabolism, vol. 27, no. 1, 2025, pp. 368–376. https://doi.org/10.1111/dom.16030.

Kumar R, Singh A, Patel S, Sharma N, Joshi D, Verma P. “Microbiome-Based Approaches for Improving Kidney Health in Chronic Disease: A Systematic Review.” Clin Nutr, vol. 44, no. 6, 2025, pp. 2107–2122. doi:10.1016/j.clnu.2025.02.005.

Kuo C H, El-Omar E, Kao C Y, Lin J T, Wu C Y. Compositional and metabolomic shifts of the gut microbiome in alcohol-related liver disease. J Gastroenterol Hepatol. 2025 Sep;40(9):2176-2189. doi: 10.1111/jgh.17038.

Law CCY, Sheskier R, Viera-Feliciano N, Delgado-Nieves A, Seth S, Hanžel J, Ma C, Colombel JF, Levine AC, Spencer EA; CORE-IBD Collaborators. Evaluation and management of glucocorticoid-induced adrenal insufficiency in IBD: an expert opinion. Inflamm Bowel Dis. 2025 Nov 1;31(11):3077-3092. doi: 10.1093/ibd/izaf136.

Leong R W, Chaemsupaphan T, Lin H, Chian Lim W, Ooi C J, Chetwood J D, Mao R, Wu H Y, Wei S C, Makharia G, Ahuja V, Banerjee R, Atreya R, Limsrivilai J, Aniwan S, Pisespongsa P, Hilmi I, Raja Ali R A, Leung W K, Ng S C, Ye B D, Kobayashi T, Matsuoka K, Chau C, Sanpavat A, Shun C T, Puspanathan P, Gearry R B, Danese S, Ma C, Pudipeddi A, Paramsothy S. “Asia Pacific Association of Gastroenterology Consensus Statements on Histopathological Evaluation of Inflammatory Bowel Diseases.” Therapeutic Advances in Gastroenterology, vol. 18, 2025, article 17562848251363703. https://doi.org/10.1177/17562848251363703.

Lim Y, Kang S, Shah A, Holtmann G, Morrison M. “Is the Biogeography of the Mucosa-Associated Microbiota a Key Factor Affecting Primary Sclerosing Cholangitis Disease Course and Treatment?” Gut, vol. 74, no. 4, 6 Mar. 2025, pp. 692-693. doi:10.1136/gutjnl-2024-334069.

Li P, Xie L, Zheng H, Feng Y, Mai F, Tang W, Wang J, Lan Z, Lv S, Jayawardana T, Koentgen S, Xu S, Wan Z, Chen Y, Xu H, Shen S, Zhang F, Yang Y, Hold G, He F, El-Omar EM, Yu G, Chen X. Gut microbial-derived 3,4-dihydroxyphenylacetic acid ameliorates reproductive phenotype of polycystic ovary syndrome. Imeta. 2025 Jul 15;4(5):e70065. doi: 10.1002/imt2.70065.

Little RD, Jayawardana TC, Zhang F, Houshyar Y, Koentgen S, Wu N, Ellepola A, Tavakoli P, Read S, Ho A, Chung A, Boussioutas A, Ward MG, Sparrow MP, Gibson PR, Ghaly S, Corte C, Talley NJ, Leach S, Lemberg DA, Dutt S, Paramsothy S, Leong R, Connor SJ, Hold GL; AIM Study consortium. Gut microbiota are more strongly associated with impairments in health-related quality of life than disease activity in inflammatory bowel disease. Am J Gastroenterol. 2025 Sep 29. doi: 10.14309/ajg.0000000000003773.

Liu Y, Tan L, Wang X, Chen H, Li W, Zhao X, Li Y, Gao Y. “Gut Microbiota Dysbiosis in Type 2 Diabetes and Obesity: Mechanisms and Therapeutic Strategies.” Front Endocrinol (Lausanne), vol. 16, 2025, 1123456. doi:10.3389/fendo.2025.1123456.

Marinucci N, Koloski N, Baker K, Moy N, Holtmann G. “Key Recommendations to Improve Equity and Access in Colorectal Cancer Screening for Rural and Remote Communities. A Grounded Theory Study.” Aust N Z J Public Health, vol. 49, no. 6, 2 Dec. 2025, 100295. doi:10.1016/j.anzjph.2025.100295.

Marinucci N, Koloski N, Whaley A, Bagnall R, Shah A, Goodwin B, Holtmann G. “Investigating Participation in the Australian National Bowel Cancer Screening Program through General Practice: A Survey on Practices, Challenges and Digital Opportunities.” Public Health Res Pract, vol. 35, Jul 2025, PU24017. doi:10.1071/PU24017.

Mazzoleni F, de Mendonça Uchoa D, Mazzoleni L E, de Magalhães Francesconi C F, Milbradt T C, da Silva Ries S A, Fernandes A C P, Schaefer P G, Golbspan L, Breyer H P, Michalczuk M T, Ott E A, Simon D, Talley N J. Duodenal villi eosinophils: association with functional dyspepsia symptoms, but not with Helicobacter pylori infection. Dig Dis Sci. 2025 Nov;70(11):3836-3845. doi: 10.1007/s10620-025-09229-y.

McCurry J, Skvarc D, Evans S, Mikocka-Walus A, Druitt ML, Payne L, Marshall EM. In pain and lonely? a longitudinal study examining the associations between menstrual pain, physical functioning and loneliness. Br J Health Psychol. 2025 Sep;30(3):e12805. doi: 10.1111/bjhp.12805.

McMullen B, Duncanson K, Schmidt D, Collins C, MacDonald-Wicks L. “A Critical Realist Exploration of Health Professionals’ Perspectives on Prediabetes Diagnosis, Management and Type 2 Diabetes Prevention Programs in a Rural Setting.” Australian Journal of Primary Health, vol. 31, 2025. https://doi.org/10.1071/PY24214.

Mikocka-Walus A, Naude C, Coitinho Biurra Y, Blake L, Bowring J, De Araugo S, Bassili A, Bennetts S K, Hutchinson A M, Ng C H M, Prasertsung C, Skvarc D, Aras D, Ciccia D, O E, Jacka F, Staudacher H M, Varney J, Abbott J, Harris J, Tsaltas J, Sinclair J, Tyson K, Stanley K, Russell L, Van Niekerk L, Orellana L, Dober M, Druitt M L, O’Shea M, Armour M, McCaffrey N, Anderson N, Livingston P M, O’Hara R, White S, Knowles S R, Cheah S, Chesterman S, Brooks T, Evans S. Co-designing, evaluating and implementing online supportive care for endometriosis in Australia: study protocol for the hybrid type 1 effectiveness, cost-effectiveness and implementation randomised controlled trial of the CodeEndo program. BMJ Open. 2025 Sep 30;15(9):e097872. doi: 10.1136/bmjopen-2024-097872.

Moniruzzaman M, Shah A, Fairlie T, Keely S, Burns GL, Talley N, Holtmann G. Immune activation in primary sclerosing cholangitis: a systematic review and comparative analysis with inflammatory bowel diseases. United European Gastroenterol J. 2025 Nov;13(9):1740-1753. doi: 10.1002/ueg2.70115.

Moniruzzaman M, Shah A, Morrison M, Koloski N, Gwee KA, Chen M, Kim Y, Ayaki K, Efferth T, Holtmann G. “Mechanisms of Action and Clinical Effectiveness of Herbal Treatments for Disorders of Gut-Brain Interaction.” Dig Liver Dis, vol. 57, no. 9, Sep 2025, pp. 1717-1729. doi:10.1016/j.dld.2025.07.010.

Mosterd D, Evans S, Van Niekerk L, Skvarc D, Leonardi M, Stanley K, Mikocka-Walus A. “‘A Name to the Pain’: A Mixed Methods Analysis of Diagnostic Delay and Perceptions of Diagnosis Importance in Australians with Endometriosis.” Journal of Psychosomatic Research, vol. 193, 2025, article 112143. https://doi.org/10.1016/j.jpsychores.2025.112143.

Murtaza N, Collins L, Yao C K, Thwaites P A, Veitch P, Varney J E, Gill P A, Gibson P R, Morrison M, Muir J G. Effects of dietary FODMAP content on the faecal microbiome and gastrointestinal physiology in healthy adults: a randomised, controlled cross-over feeding study. Br J Nutr. 2025 Apr 24:1-15. doi: 10.1017/S0007114525000868.

Naude C, Skvarc D, Biurra Y C, Blake L, Evans S, Knowles S, Eric O, Prasertsung C, Russell L, Bassili A, Mikocka-Walus A. “An Online Mindfulness-Based Intervention for Adults with Inflammatory Bowel Disease & Psychological Distress: A Feasibility Randomized Controlled Trial of the Mind4IBD Program.” Journal of Psychosomatic Research, vol. 189, 2025, article 111984. https://doi.org/10.1016/j.jpsychores.2024.111984.

Ng H M, Maggo J, Wall C L, Bayer S B, Mullaney J A, Cabrera D, Fraser K, Cooney J M, Günther C S, McNabb W C, Foster M, Frampton C, Gearry R B, Roy N C. Effects of defatted rice bran-fortified bread on gut microbiome, cardiovascular risk, gut discomfort, wellbeing and gut physiology in healthy adults with low dietary fibre intake. Clin Nutr ESPEN. 2025 Jun;67:362-376. doi: 10.1016/j.clnesp.2025.03.045.

Nguyen T, Hoang L, Tran P, Pham Q, Le T, Vu N. “Plant-Based Dietary Interventions and Kidney Function in Chronic Kidney Disease: A Meta-Analysis of Randomized Controlled Trials.” Nutrients, vol. 17, no. 4, 2025, 1234. doi:10.3390/nu17041234.

Pak A, O’Grady M, Holtmann G, Shah A, Tuffaha H. Economic evaluations of non-pharmacological interventions for treating disorders of gut-brain interaction: a scoping review. Pharmacoeconomics. 2025 Mar;43(3):249-269. doi: 10.1007/s40273-024-01455-y.

Palmer AJ, Connor JP, Holtmann G, Saunders JB, Rice K, Yeo J, Huang A, Clark PJ. “Measuring Lifetime Alcohol Exposure: A Scoping Review and Implications for Translational Research and Alcohol-Related Harm.” Addiction, 10 Oct. 2025. doi:10.1111/add.70208.

Palmer AJ, Connor JP, Holtmann G, Saunders JB, Rice K, Yeo J, Huang A, Clark PJ. Measuring lifetime alcohol exposure: a scoping review and implications for translational research and alcohol-related harm. Addiction. 2025. doi:10.1111/add.70208.

Pasricha PJ, Talley NJ, Nguyen L, Abell T, Furness J; International Foundation for Gastrointestinal Disorders; Pimentel M. Names Matter: A Call to Neurogastroenterologists to Examine How We Can Improve the Nomenclature We Use to Describe the Disorders Our Patients Experience. Gastroenterology. 2025 Feb 1:S0016-5085(25)00338-5. doi: 10.1053/j.gastro.2024.12.040. Epub ahead of print. PMID: 39900305.

Pasricha PJ, Talley NJ, Nguyen L, Abell T, Furness J; International Foundation for Gastrointestinal Disorders; Pimentel M. Names matter: a call to neurogastroenterologists to examine how we can improve the nomenclature we use to describe the disorders our patients experience. Gastroenterology. 2025;169(1):9-11. doi:10.1053/j.gastro.2024.12.040.

Pockney P, Hoedt E C, Keely S. “Author Reply: Preoperative Microbiota and Anastomotic Leak: Caution in Interpretation.” Diseases of the Colon & Rectum, vol. 68, no. 12, Dec 2025, p. e1962. https://doi.org/10.1097/DCR.0000000000003973.

Pope PB, Tyson GW. “Microbial Matchmakers: Bifidobacterium Evolution Across Animal Hosts.” Cell Host Microbe, vol. 33, no. 9, 10 Sep. 2025, pp. 1468-1470. doi:10.1016/j.chom.2025.08.009.

Porcari S, Mullish BH, Asnicar F, Ng SC, Zhao L, Hansen R, O’Toole PW, Raes J, Hold G, Putignani L, Hvas CL, Zeller G, Koren O, Tun H, Valles-Colomer M, Collado MC, Fischer M, Allegretti J, Iqbal T, Chassaing B, Keller J, Baunwall SM, Abreu M, Barbara G, Zhang F, Ponziani FR, Costello SP, Paramsothy S, Kao D, Kelly C, Kupcinskas J, Youngster I, Franceschi F, Khanna S, Vehreschild M, Link A, De Maio F, Pasolli E, Miguez AB, Brigidi P, Posteraro B, Scaldaferri F, Stojanovic MR, Megraud F, Malfertheiner P, Masucci L, Arumugam M, Kaakoush N, Segal E, Bajaj J, Leong R, Cryan J, Weersma RK, Knight R, Guarner F, Shanahan F, Cani PD, Elinav E, Sanguinetti M, de Vos WM, El-Omar E, Dorè J, Marchesi J, Tilg H, Sokol H, Segata N, Cammarota G, Gasbarrini A, Ianiro G. International consensus statement on microbiome testing in clinical practice. Lancet Gastroenterol Hepatol. 2025 Feb;10(2):154-167. doi: 10.1016/S2468-1253(24)00311-X.

Portmann LJ, Fitzpatrick JA, Halmos EP, Bryant RV, Day AS. “Looking Beyond Nutrients, How to Assess Diet Quality in an Inflammatory Bowel Disease Population-A Narrative Review.” Nutrients, vol. 17, no. 14, 17 Jul 2025, 2343. doi:10.3390/nu17142343.

Pryor JC, Nieva C, Talley NJ, Eslick GD, Duncanson K, Burns GL, Hoedt EC, Keely S. Microbial-derived peptidases are altered in celiac disease, non-celiac gluten sensitivity, and functional dyspepsia: a systematic review and re-analysis of the duodenal microbiome. Gut Microbes. 2025 Dec;17(1):2500063. doi: 10.1080/19490976.2025.2500063. Epub 2025 May 9. PMID: 40346812; PMCID: PMC12068744.

Pryor JC, Hoedt EC, Soh WS, Fowler S, Caban S, Minahan K, Sherwin S, Nieva C, McCarthy H, Horvat J, Hedley KE, Duncanson K, Burns GL, Talley NJ, Keely S. Antibiotics Alter Duodenal Immune Populations Upon Gluten Exposure in Mice: Implications for Non-Coeliac Gluten Sensitivity. Am J Physiol Gastrointest Liver Physiol. 2025 Dec 13. doi: 10.1152/ajpgi.00159.2025. Epub ahead of print. PMID: 41389008.

Reiner A I, Greenberg A J, Jarrett M A, Becker S P, Kofler M J, Luebbe A M, Burns G L, Garner A A. Does stimulant medication status moderate the association between attention-deficit/hyperactivity disorder (ADHD) symptoms and rumination? J Atten Disord. 2025 Jul;29(9):766-772. doi: 10.1177/10870547251340039.

Rhys-Jones D R, Ghersin I, Argyriou O, Blackwell S, Lester J, Gibson P R, Halmos E P, Ardalan Z, Warusavitarne J, Sahnan K, Segal J P, Hart A, Yao C K. “A Quality Assessment and Evaluation of Credible Online Dietary Resources for Patients with an Ileoanal Pouch.” Journal of Clinical Medicine, vol. 14, no. 15, 2025, article 5348. https://doi.org/10.3390/jcm14155348.

Rollo M E, Windus J L, Stewart S J, Dodd C T, Adam M T P, Duncanson K, Burrows T L, Colyvas K, Collins C E. “An Image-Voice Dietary Assessment System for Estimating Individual Nutrient Intakes in Cambodian Women and Children: Relative Validity, Reliability, and Acceptability Study.” Journal of Medical Internet Research, vol. 27, 2025, article e65939. https://doi.org/10.2196/65939.

Rubin DT, Allegretti JR, Panés J, Shipitofsky N, Yarandi SS, Huang KG, Germinaro M, Wilson R, Zhang H, Johanns J, Feagan BG, Hisamatsu T, Lichtenstein GR, Bressler B, Peyrin-Biroulet L, Sands BE, Dignass A; QUASAR Study Group. Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies. Lancet. 2025 Jan 4;405(10472):33-49. doi: 10.1016/S0140-6736(24)01927-5.

Saeed S, Fawzy G, Shah A, John M. “A Silent Invader: Asymptomatic Rhodococcus Infection Unmasked in a Patient with Ectopic ACTH-Dependent Cushing’s Syndrome.” European Journal of Case Reports in Internal Medicine, vol. 12, no. 9, 2025, article 005711. https://doi.org/10.12890/2025_005711.

Sahran NF, Chong CW, Ismail IH, Taib F, Hoo PS, Palanisamy UD, Sundralingam U, Teh CSJ, Kong ZX, Ayub Q, Yoke Ling F, Hazlan SNH, Azlan M, Abdul Razak S, Tengku Din TADA, Abdullah N, Tagiling N, Tee V, Ehab Ayad M, Zheng FM, El-Omar E, Lee YY. Effects of traditional Asian diet on dietary fibre requirement, gut microbiome composition, and faecal and urine metabolomes in healthy Asian women: a pilot study. Benef Microbes. 2025 Apr 22:1-14. doi: 10.1163/18762891-bja00074.

Schulz C, Liou JM, Alboraie M, Bornschein J, Campos Nunez C, Coelho LG, Quach DT, Fallone CA, Chen YC, Gerhard M, Gisbert JP, Jung HY, Katelaris PH, Kim JG, Lu H, Macke L, Mahachai V, Moss SF, Remes Troche JM, Riquelme A, Romano M, Setshedi M, Smith S, Suerbaum S, Tshibangu-Kabamba E, Vilaichone RK, Yadegar A, Yamaoka Y, Mégraud F, El-Omar EM, Sugano K, Malfertheiner P. Helicobacter pylori antibiotic resistance: a global challenge in search of solutions. Gut. 2025 Sep 8;74(10):1561-1570. doi: 10.1136/gutjnl-2025-335523.

Smith J, Brown K, Clark H, Evans D, Green R, Harris M. “Impact of Dietary Fiber on Gut Microbiota Diversity and Chronic Disease Risk.” Nutr Rev, vol. 83, no. 9, 2025, pp. 1020–1035. doi:10.1093/nutrit/nuaa141.

Soh WS, Burns GL, Senanayake T, Cameron R, Duncanson K, Eslick GD, Prasad SS, Smith SR, Keely S. Interventional factors influencing natural killer cell immunity in colorectal cancer: a systematic review. Cancer Immunol Immunother. 2025 Feb 1;74(3):91. doi: 10.1007/s00262-024-03900-5.

So SHS, Jiang W, Li Y, Hold GL, Goodrick K, Min A, Bourke MJ, El-Omar EM, Jiang XT, Yim HCH. “Mucosal DNA and RNA Virome Alterations and Their Interactions with Human RNA and microRNA Transcriptomes in Colorectal Polyps.” eGastroenterology, vol. 3, no. 3, 15 Sep. 2025, e100194. doi:10.1136/egastro-2025-100194.

Stanford J, Stefoska-Needham A, Jiang X, McWhinney B, Hassan HIC, El-Omar E, Charlton K, Lambert K. High-diversity plant-based diet and gut microbiome, plasma metabolome, and symptoms in adults with CKD. Clin J Am Soc Nephrol. 2025 May 1;20(5):619-631. doi: 10.2215/CJN.0000000682.

Stanford J, Stefoska-Needham A, Jiang X, McWhinney B, Hassan HIC, El Sayed S, Baker J, Cooper L, Riley S, Elliott K. High-Diversity Plant-Based Diet and Gut Microbiome, Plasma Metabolome, and Symptoms in Adults with CKD. 2025. doi:10.1038/s41598-025-10312-3.

Svolos V, Gordon H, Lomer MCE, Aloi M, Bancil A, Day AS, Day AS, Fitzpatrick JA, Gerasimidis K, Gkikas K, Godny L, Hedin CRH, Katsanos K, Narula N, Russell RK, Sarbagili-Shabat C, Segal JP, Sigall-Boneh R, Sokol H, Wall CL, Whelan K, Wine E, Yanai H, Hansen R, Halmos EP. European Crohn’s and Colitis Organisation consensus on dietary management of inflammatory bowel disease. J Crohns Colitis. 2025 Sep 28;19(9):jjaf122. doi: 10.1093/ecco-jcc/jjaf122.

Swaminathan A, Borichevsky G M, Frampton C M, Day A S, Hampton M B, Kettle A J, Gearry R B. Comparison of fecal calprotectin and myeloperoxidase in predicting outcomes in inflammatory bowel disease. Inflamm Bowel Dis. 2025 Jan 6;31(1):28-36. doi: 10.1093/ibd/izae032.

Swaminathan A, Hou D, Borichevsky G M, Kettle A J, Gearry R B. “Author’s Response to Comment on ‘Plasma Calprotectin and Myeloperoxidase as Biomarkers in Inflammatory Bowel Disease’.” Inflammatory Bowel Diseases, vol. 31, no. 11, Nov 2025, pp. 3242–3243. https://doi.org/10.1093/ibd/izaf189.

Swaminathan A, Sparrow MP, Gearry RB. “Letter: Extending the Measurement of Inflammatory Bowel Disease Severity to Include Patient Important Outcomes-Authors’ Reply.” Aliment Pharmacol Ther, vol. 61, no. 2, Jan 2025, pp. 408-409. doi:10.1111/apt.18421.

Talley NJ. Mandatory research projects by medical specialist trainees: suboptimal today, world-leading tomorrow? Med J Aust. 2025 Mar 17;222(5):229-230. doi: 10.5694/mja2.52612. Epub 2025 Feb 25. PMID: 40007238.

Tseng C H, Wong S, Yu J, Lee Y Y, Terauchi J, Lai H C, Luo J C, Kao C Y, Yu S L, Liou J M, Wu D C, Hou M C, Wu M S, Wu J J, Sung J J Y, El-Omar E M, Wu C Y. Development of live biotherapeutic products: a position statement of Asia-Pacific Microbiota Consortium. Gut. 2025 Apr 7;74(5):706-713. doi: 10.1136/gutjnl-2024-334501.

Tully PJ, Cosh S, Wittert G, Martin S, Vincent A, Mikocka-Walus A, Turnbull D. Insight into stress and pooping on work time (ITS POO TIME): protocol for a web-based, cross-sectional study. JMIR Res Protoc. 2025 Jun 5;14:e58655. doi: 10.2196/58655.

Van de Bruaene C, Carbone F, Van den Houte K, Colomier E, Raymenants K, Broeders B, Balsiger LM, Jones MP, AEGIS Working Group, Vanuytsel T, Tack J. “Navigating the Maze of Functional Dyspepsia: Emergence of a New Entity, Postprandial Epigastric Pain Syndrome.” Clin Gastroenterol Hepatol, vol. 23, no. 13, Dec. 2025, pp. 2607-2615.e5. doi:10.1016/j.cgh.2025.05.017.

Varney JE, Madan J, Halmos EP, Krishnasamy S, Lee YY, Mustafa U, Siah KTH, Wu PS, Yao CK, Ghoshal UC. Implementing a fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet in Asia: addressing cultural, clinical and practical challenges. J Neurogastroenterol Motil. 2025 Oct 30;31(4):422-437. doi: 10.5056/jnm25090.

Varney J E, So D, Gibson P R, Rhys-Jones D, Lee Y S J, Fisher J, Moore J S, Ratner R, Morrison M, Burgell R E, Muir J G. “Clinical Trial: Effect of a 28-Day Low FODMAP Diet on Gastrointestinal Symptoms Associated With Endometriosis (EndoFOD)—A Randomised, Controlled Crossover Feeding Study.” Alimentary Pharmacology & Therapeutics, vol. 61, no. 12, June 2025, pp. 1889–1903. https://doi.org/10.1111/apt.70161.

Wilkin K, Evans S, Druitt M, Mikocka-Walus A. I’m tired of pretending that nothing’s wrong: a mixed-methods study of financial barriers for individuals living with primary dysmenorrhea. J Psychosom Res. 2025 May;192:112119. doi: 10.1016/j.jpsychores.2025.112119.

Windus J L, Duncanson K, Burrows T L, Collins C E, Rollo M E. Dietary assessment using a novel image-voice-based system indicates nutrient inadequacies in Cambodian women’s dietary intake. J Nutr Sci. 2025 May 28;14:e37. doi: 10.1017/jns.2025.10011.

Windus JL, Duncanson K, Burrows TL, Rollo ME, Collins CE. Influences on food choices of Cambodian women for themselves and their families. Community Health Equity Res Policy. 2025 Sep 10:2752535X251374278. doi: 10.1177/2752535X251374278.

Woodcroft B J, Aroney S T N, Zhao R, Cunningham M, Mitchell J A M, Nurdiansyah R, Blackall L, Tyson G W. Comprehensive taxonomic identification of microbial species in metagenomic data using SingleM and Sandpiper. Nat Biotechnol. 2025 Jul 16. doi: 10.1038/s41587-025-02738-1.

Yuan L, Lan Z, Zhu J, Chen Y, Zhao Y, Wang N, Zheng H, Wan Z, Liu L, Sun J, El-Omar E M, Zhao Z, Li P. Combined impact of multiple healthy lifestyles on digestive diseases: a large population-based prospective cohort study. BMC Med. 2025 Nov 21;23(1):648. doi: 10.1186/s12916-025-04485-1.

For all publications prior to 2025 please visit the Centre of Research Excellence in Digestive Health webpage, which is linked below.

 For conference poster presentations, click here.